Relevance of prediction scores derived from the SARS-CoV-2 first wave, in the evolving UK COVID-19 second wave, for safe early discharge and mortality: a PREDICT COVID-19 UK prospective observational cohort study

被引:1
|
作者
Ghani, Hakim [1 ]
Navarra, Alessio [1 ]
Pyae, Phyoe K. [1 ]
Mitchell, Harry [1 ]
Evans, William [1 ]
Cama, Rigers [1 ]
Shaw, Michael [1 ]
Critchlow, Ben [1 ]
Vaghela, Tejal [1 ]
Schechter, Miriam [1 ]
Nordin, Nazril [1 ]
Barlow, Andrew [1 ]
Vancheeswaran, Rama [1 ]
机构
[1] West Hertfordshire Hosp NHS Trust, Watford, England
来源
BMJ OPEN | 2022年 / 12卷 / 12期
关键词
COVID-19; telemedicine; health & safety; organisation of health services; general medicine (see internal medicine);
D O I
10.1136/bmjopen-2021-054469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProspectively validate prognostication scores, SOARS and 4C Mortality Score, derived from the COVID-19 first wave, for mortality and safe early discharge in the evolving pandemic with SARS-CoV-2 variants (B.1.1.7 replacing D614) and healthcare responses altering patient demographic and mortality.DesignProtocol-based prospective observational cohort study.SettingSingle site PREDICT and multisite ISARIC (International Severe Acute Respiratory and Emerging Infections Consortium) cohorts in UK COVID-19 second wave, October 2020 to January 2021.Participants1383 PREDICT and 20595 ISARIC SARS-CoV-2 patients.Primary outcome measuresRelevance of SOARS and 4C Mortality Score determining in-hospital mortality and safe early discharge in the evolving UK COVID-19 second wave.Results1383 (median age 67 years, IQR 52-82; mortality 24.7%) PREDICT and 20595 (mortality 19.4%) ISARIC patient cohorts showed SOARS had area under the curve (AUC) of 0.8 and 0.74, while 4C Mortality Score had AUC of 0.83 and 0.91 for hospital mortality, in the PREDICT and ISARIC cohorts respectively, therefore, effective in evaluating safe discharge and in-hospital mortality. 19.3% (231/1195, PREDICT cohort) and 16.7% (2550/14992, ISARIC cohort) with SOARS of 0-1 were candidates for safe discharge to a virtual hospital (VH) model. SOARS implementation in the VH pathway resulted in low readmission, 11.8% (27/229) and low mortality, 0.9% (2/229). Use to prevent admission is still suboptimal, as 8.1% in the PREDICT cohort and 9.5% in the ISARIC cohort were admitted despite SOARS score of 0-1.ConclusionsSOARS and 4C Mortality Score remains valid, transforming complex clinical presentations into tangible numbers, aiding objective decision making, despite SARS-CoV-2 variants and healthcare responses altering patient demographic and mortality. Both scores, easily implemented within urgent care pathways for safe early discharge, allocate hospital resources appropriately to the pandemic's needs while enabling normal healthcare services resumption.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] SARS-CoV-2 variants and spike mutations involved in second wave of COVID-19 pandemic in India
    Muttineni, Radhakrishna
    Binitha, R. N.
    Putty, Kalyani
    Marapakala, Kavitha
    Sandra, K. P.
    Panyam, Jaslin
    Vemula, Aravind
    Singh, Shashi Mohan
    Balachandran, Subin
    Rao, Viroji S. T.
    Kondapi, Anand Kumar
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (05) : E1721 - E1733
  • [32] Sex and Gender-Related Differences in COVID-19 Diagnoses and SARS-CoV-2 Testing Practices During the First Wave of the Pandemic: The Dutch Lifelines COVID-19 Cohort Study
    Ballering, Aranka Vivienne
    Oertelt-Prigione, Sabine
    Hartman, Tim C. Olde
    Rosmalen, Judith G. M.
    JOURNAL OF WOMENS HEALTH, 2021, 30 (12) : 1686 - 1692
  • [33] Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France
    Fitoussi, Frederic
    Dupont, Raphael
    Tonen-Wolyec, Serge
    Belec, Laurent
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4351 - 4357
  • [34] Skin manifestations in patients with COVID-19: a prospective observational study during the first wave of the pandemic in the UK and review of the recent literature
    Parmar, Shivani
    De Silva, Bernadette
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (01) : 77 - 85
  • [35] Skin manifestations in patients with COVID-19: a prospective observational study during the first wave of the pandemic in the UK and review of the recent literature
    Shivani Parmar
    Bernadette De Silva
    European Journal of Dermatology, 2022, 32 : 77 - 85
  • [36] SARS-CoV-2 infection in pregnancy during the first wave of COVID-19 in the Netherlands: a prospective nationwide population-based cohort study (NethOSS)
    Overtoom, E. M.
    Rosman, A. N.
    Zwart, J. J.
    Vogelvang, T. E.
    Schaap, T. P.
    van den Akker, T.
    Bloemenkamp, K. W. M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 (01) : 91 - 100
  • [37] Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
    Adetifa, Ifedayo M. O.
    Uyoga, Sophie
    Gitonga, John N.
    Mugo, Daisy
    Otiende, Mark
    Nyagwange, James
    Karanja, Henry K.
    Tuju, James
    Wanjiku, Perpetual
    Aman, Rashid
    Mwangangi, Mercy
    Amoth, Patrick
    Kasera, Kadondi
    Ng'ang'a, Wangari
    Rombo, Charles
    Yegon, Christine
    Kithi, Khamisi
    Odhiambo, Elizabeth
    Rotich, Thomas
    Orgut, Irene
    Kihara, Sammy
    Bottomley, Christian
    Kagucia, Eunice W.
    Gallagher, Katherine E.
    Etyang, Anthony
    Voller, Shirine
    Lambe, Teresa
    Wright, Daniel
    Barasa, Edwine
    Tsofa, Benjamin
    Bejon, Philip
    Ochola-Oyier, Lynette, I
    Agweyu, Ambrose
    Scott, J. Anthony G.
    Warimwe, George M.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [38] Multiple pathways of SARS-CoV-2 nosocomial transmission uncovered by integrated genomic and epidemiological analyses during the second wave of the COVID-19 pandemic in the UK
    Cook, Kate F. F.
    Beckett, Angela H. H.
    Glaysher, Sharon
    Goudarzi, Salman
    Fearn, Christopher
    Loveson, Katie F. F.
    Elliott, Scott
    Wyllie, Sarah
    Lloyd, Allyson
    Bicknell, Kelly
    Lumley, Sally
    Chauhan, Anoop J. J.
    Robson, Samuel C. C.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [39] SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada
    Saeed, Sahar
    Drews, Steven J.
    Pambrun, Chantale
    Yi, Qi-Long
    Osmond, Lori
    O'Brien, Sheila F.
    TRANSFUSION, 2021, 61 (03) : 862 - 872
  • [40] Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
    Ifedayo M. O. Adetifa
    Sophie Uyoga
    John N. Gitonga
    Daisy Mugo
    Mark Otiende
    James Nyagwange
    Henry K. Karanja
    James Tuju
    Perpetual Wanjiku
    Rashid Aman
    Mercy Mwangangi
    Patrick Amoth
    Kadondi Kasera
    Wangari Ng’ang’a
    Charles Rombo
    Christine Yegon
    Khamisi Kithi
    Elizabeth Odhiambo
    Thomas Rotich
    Irene Orgut
    Sammy Kihara
    Christian Bottomley
    Eunice W. Kagucia
    Katherine E. Gallagher
    Anthony Etyang
    Shirine Voller
    Teresa Lambe
    Daniel Wright
    Edwine Barasa
    Benjamin Tsofa
    Philip Bejon
    Lynette I. Ochola-Oyier
    Ambrose Agweyu
    J. Anthony G. Scott
    George M. Warimwe
    Nature Communications, 12